Oh, that "though" though, Mr. Downramping Doc....
It is not unusual to want to focus on the subroup of patients with the greatest response. That doesn't negate the VERY promising outcome of 65 percent reduction in heart attack and stroke across the entire patient population.
"Interesting and potentially promising "? Talk about damning with faint praise.
MSB 2022 - The road to commercialisation, page-961
-
- There are more pages in this discussion • 568 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.020(1.50%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.40 | $1.34 | $3.562M | 2.615M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 17969 | 2 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |